BioNTech SE (BNTX) Goodwill & Intangibles (2018 - 2025)
BioNTech SE (BNTX) reported Goodwill & Intangibles of $2.3 billion for Q4 2025, up 83.62% on a YoY basis from $1.3 billion in Q4 2024, and up 12.47% sequentially from $2.0 billion in Q3 2025.
BioNTech SE (BNTX) Goodwill & Intangibles (2018 - 2025) Analysis & Trends
BioNTech SE (BNTX) has 8 years of Goodwill & Intangibles data on file, last reported at $2.3 billion in Q4 2025.
- For the quarter ending Q4 2025, Goodwill & Intangibles rose 83.62% year-over-year to $2.3 billion; the trailing twelve-month figure through Dec 2025 stood at $2.3 billion (up 83.62% YoY), and the FY2025 full-year result was $2.2 billion, up 78.22% from the prior year.
- Goodwill & Intangibles rose to $2.3 billion in Q4 2025, from $2.0 billion in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $2.3 billion in Q4 2025 to a low of $132.2 million in Q4 2021.
- A 5-year average of $935.6 million and a median of $834.2 million in 2023 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles sank 57.44% in 2021 and surged 392.15% in 2023, its largest moves.
- Tracing BNTX's Goodwill & Intangibles over 5 years: stood at $132.2 million in 2021, then jumped by 118.72% to $289.2 million in 2022, then surged by 333.96% to $1.3 billion in 2023, then retreated by 0.31% to $1.3 billion in 2024, then jumped by 83.62% to $2.3 billion in 2025.
- Business Quant data shows BNTX's Goodwill & Intangibles at $2.3 billion in Q4 2025, $2.0 billion in Q3 2025, and $2.1 billion in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BioNTech SE | 22.13 Bn | 22.13 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.30 Bn |
| Sep 30, 2025 | 2.04 Bn |
| Jun 30, 2025 | 2.10 Bn |
| Mar 31, 2025 | 1.99 Bn |
| Dec 31, 2024 | 1.25 Bn |
| Sep 30, 2024 | 1.37 Bn |
| Jun 30, 2024 | 1.33 Bn |
| Mar 31, 2024 | 1.29 Bn |
| Dec 31, 2023 | 1.26 Bn |
| Sep 30, 2023 | 1.12 Bn |
| Jun 30, 2023 | 545.99 Mn |
| Mar 31, 2023 | 406.37 Mn |
| Dec 31, 2022 | 289.24 Mn |
| Sep 30, 2022 | 228.07 Mn |
| Jun 30, 2022 | 236.25 Mn |
| Mar 31, 2022 | 242.42 Mn |
| Dec 31, 2021 | 132.24 Mn |
| Sep 30, 2021 | 192.11 Mn |
| Jun 30, 2021 | 197.62 Mn |
| Mar 31, 2021 | 199.27 Mn |